There are dozens of studies, innovations, and research findings released everyday by institutions and clinics across the world. Here’s a look at some of the other notable health reports from May 20-22.
Journal of Parkinson’s Disease Welcomes New Co-Editor-in-Chief Lorraine V. Kalia, MD, PhD, FRCPC
A globally recognized authority on Parkinson’s disease, Lorraine V. Kalia, MD, PhD, FRCPC, is an Associate Professor and Clinician Scientist in the Division of Neurology at the University of Toronto and a Senior Scientist at the Krembil Research Institute of the University Health Network.
Deciphering the biosynthetic gene cluster for potent freshwater toxin
Scientists from Scripps Institution of Oceanography at the University of California San Diego, the University of São Paulo and UC Santa Cruz collaborated to discover and validate the enzymes responsible for the production ofone of the most toxic and fast-acting neurotoxins associated with freshwater harmful algal blooms in lakes and ponds.
Resolution Time of COVID Vaccine-Related Lymphadenopathy
According to ARRS’ American Journal of Roentgenology (AJR), axillary lymphadenopathy detected by breast ultrasound after COVID-19 mRNA vaccination lasts longer than reported in initial vaccine clinical trials.
New Guidance Released for Preventing Hospital-Acquired Pneumonia
In the second in series of updates on guidance for infection control in acute-care hospitals, five medical organizations are recommending best practices for preventing hospital-associated pneumonia.
ZBP1 links interferon treatment and dangerous inflammatory cell death during COVID-19
Scientists from St. Jude Children’s Research Hospital have shown that the innate immune sensor, ZBP1, and its associated inflammatory cell death pathway, PANoptosis, are major contributors to the negative effects of interferon treatment and high interferon levels in some COVID-19 patients.